End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
16.67 MXN | +2.27% | +8.60% | +17.73% |
Sales 2023 | 16.47B 972M | Sales 2024 * | 18.2B 1.07B | Capitalization | 15.53B 917M |
---|---|---|---|---|---|
Net income 2023 | 1.03B 60.88M | Net income 2024 * | 2.18B 128M | EV / Sales 2023 | 1.07 x |
Net Debt 2023 | 4.52B 267M | Net Debt 2024 * | 1.97B 116M | EV / Sales 2024 * | 0.96 x |
P/E ratio 2023 |
13.1
x | P/E ratio 2024 * |
7.6
x | Employees | 1,783 |
Yield 2023 |
1.38% | Yield 2024 * |
1.39% | Free-Float | 69.81% |
Latest transcript on Genomma Lab Internacional, S.A.B. de C.V.
1 day | +2.27% | ||
1 week | +8.60% | ||
Current month | +5.64% | ||
1 month | +5.64% | ||
3 months | +17.81% | ||
6 months | +25.72% | ||
Current year | +17.73% |
Managers | Title | Age | Since |
---|---|---|---|
Marco Sparvieri
CEO | Chief Executive Officer | - | - |
Founder | - | 96-10-29 | |
Director of Finance/CFO | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Burkhard Wittek
BRD | Director/Board Member | 70 | 18-04-17 |
Founder | - | 96-10-29 | |
Director/Board Member | - | 97-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.07% | 15 M€ | -1.62% | - | |
0.04% | 31 M€ | +2.76% | - | |
0.01% | 4 M€ | -4.41% | - | |
0.01% | 117 M€ | -0.14% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-30 | 16.71 | +0.24% | 3,902,031 |
24-04-29 | 16.67 | +2.27% | 3,642,462 |
24-04-26 | 16.3 | +3.16% | 4,739,936 |
24-04-25 | 15.8 | +8.29% | 6,136,163 |
24-04-24 | 14.59 | -3.25% | 4,193,193 |
End-of-day quote Mexican S.E., April 28, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.73% | 911M | |
+33.25% | 699B | |
+28.59% | 571B | |
-3.55% | 364B | |
+18.16% | 326B | |
+4.36% | 286B | |
+14.81% | 236B | |
+4.93% | 198B | |
-9.78% | 194B | |
-3.69% | 149B |
- Stock Market
- Equities
- LAB B Stock